Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CLONAZEPAM Cause Electrocardiogram qt prolonged? 325 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 325 reports of Electrocardiogram qt prolonged have been filed in association with CLONAZEPAM (Clonazepam). This represents 0.8% of all adverse event reports for CLONAZEPAM.

325
Reports of Electrocardiogram qt prolonged with CLONAZEPAM
0.8%
of all CLONAZEPAM reports
25
Deaths
251
Hospitalizations

How Dangerous Is Electrocardiogram qt prolonged From CLONAZEPAM?

Of the 325 reports, 25 (7.7%) resulted in death, 251 (77.2%) required hospitalization, and 121 (37.2%) were considered life-threatening.

Is Electrocardiogram qt prolonged Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CLONAZEPAM. However, 325 reports have been filed with the FAERS database.

What Other Side Effects Does CLONAZEPAM Cause?

Drug ineffective (5,088) Toxicity to various agents (4,028) Completed suicide (3,320) Drug abuse (3,287) Off label use (2,590) Anxiety (2,376) Somnolence (2,260) Dyspnoea (1,987) Depression (1,838) Insomnia (1,836)

What Other Drugs Cause Electrocardiogram qt prolonged?

QUETIAPINE (1,869) OLANZAPINE (1,325) RIBOCICLIB (1,020) AMIODARONE (1,000) HYDROXYCHLOROQUINE (992) CLOZAPINE (958) CITALOPRAM HYDROBROMIDE (917) ESCITALOPRAM OXALATE (899) ONDANSETRON (881) BUPROPION (853)

Which CLONAZEPAM Alternatives Have Lower Electrocardiogram qt prolonged Risk?

CLONAZEPAM vs CLONIDINE CLONAZEPAM vs CLOPIDOGREL CLONAZEPAM vs CLOPIDOGREL BESILATE CLONAZEPAM vs CLOPIDOGREL BISULFATE CLONAZEPAM vs CLORAZEPATE

Related Pages

CLONAZEPAM Full Profile All Electrocardiogram qt prolonged Reports All Drugs Causing Electrocardiogram qt prolonged CLONAZEPAM Demographics